High Sensitivity SISCAPA-based Peptide Quantitation Using UHPLC and the 6490 QQQ with iFunnel Technology

Significance of the Topic

Quantitative detection of protein biomarkers at sub-ng/mL levels in complex matrices like plasma is critical for clinical research and diagnostics. High specificity and sensitivity are required to track low-abundance targets reliably. SISCAPA enrichment combined with MRM mass spectrometry addresses these challenges by concentrating target peptides and reducing sample complexity.

Objectives and Study Overview

This study aimed to demonstrate that a robust, high-throughput standard-flow LC/MS workflow using Agilent iFunnel Triple Quadrupole technology can achieve sensitivity comparable to nanoflow methods for an 11-plex SISCAPA assay. The panel targeted proteotypic peptides from ten clinically relevant proteins spanning a wide concentration range.

Methodology and Instrumentation

The workflow consisted of tryptic digestion of 10 μL plasma, followed by enrichment of 11 peptides using rabbit monoclonal antibodies immobilized on magnetic beads. A 96-well automated protocol on Agilent Bravo performed capture, wash, and elution. LC/MRM analysis employed a 2.1 x 50 mm C18 column at 600 μL/min with a 5-minute gradient. The Agilent 6490 QQQ with Jet Stream ESI, thermal gradient focusing, and dual-stage ion funnel enhanced ion transmission and sensitivity.

Instrumentation

• Agilent 1290 Infinity II LC with Eclipse Plus EC-C18 1.8 μm 2.1x50 mm column
• Agilent 6490 Triple Quadrupole MS with Jet Stream ESI and iFunnel optics
• Agilent Bravo automated liquid handling for magnetic bead SISCAPA enrichment

Main Results and Discussion

The 11-plex assay achieved detection limits down to 50 amol per 10 μL digest, with lower limits of quantitation comparable to nanoflow LC/MRM. Standard curves showed excellent linearity and precision (CV < 8 %). A 5-minute cycle time provided sixfold higher throughput and improved robustness under standard-flow conditions.

Benefits and Practical Applications

This standard-flow SISCAPA-LC/MS approach combines high sensitivity with operational stability and throughput, making it suitable for clinical laboratories and large-scale biomarker studies. Reduced analysis time and simplified maintenance support applications in QA/QC and industrial analytics.

Future Trends and Potential Applications

Advances in ion funnel technology and automated workflows will enable deeper multiplexing and even lower detection limits. Integration with next-generation MS platforms and digital laboratory systems may accelerate translation of biomarker discovery into clinical assays. Potential applications include multiplexed disease screening panels, therapeutic monitoring, and personalized medicine.

Conclusion

This work validates that standard-flow LC coupled with iFunnel-enhanced QQQ instruments can match nanoflow sensitivity for multiplexed peptide quantitation via SISCAPA. The method offers increased throughput, robustness, and operational simplicity, supporting broad adoption in biomarker analysis.

References

1. Hoofnagle et al Clinical Chemistry 2008 54(11):1796-1804 Quantification of Thyroglobulin by SISCAPA and Tandem MS
2. Anderson L et al Agilent Application Note 2011 5990-7360EN Automation of a SISCAPA Magnetic Bead Workflow on the Agilent Bravo Platform